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Percutaneous Transhepatitic Biliary Stenting
T. U. Haq,M. Sanaullah,H. Mohsin,M Y Sheikh,B. Ahmed ( Department of Radiology, The Aga Khan University Hospital,
Karachi. ) 
Abstract 
Objective: Bilary stenting with endoprosthesis is a palliative prodedure to relieve malignant biliary
obstruction. Percutaneous transhepatic technique has been employed whenever endoscopic technique
was not possible or had fialed.
Setting: Angiography intervention suite, department of radiology, Aga Khan University hospital,
Karachi.
Methods: We present retrospective analysis of 17 patients with malignant jaundice who were treated
with percutaneous techniques after the endoscopic route had failed.
Results: The success rate was 94% with placement of single plastic stent in 14 patients, double stents
in 3 patients and self-expandable stent in one patient. The overall complication rate was 41% including
sepsis, liver abscess, biloma formation, biliary leakage and stent occlusion. There was one procedure
related death due to severe sepsis.
Conclusion: Percutaneous transhepatic biliary stenting is an alternative procedure to relieve malignant
biliary obstruction with high complication rate and should be has failed (JPMA 51 :308,2001).
Introduction 
Percutaneous cholangiographv was developed originally around 1952 and made safer and more
successful by the development of the skinny (Chiba) needle in the early 1970s1 These techniques were
developed further into percutaneous biliary drainage by catheter or tube in the mid 1970s1. Malignant  
jaundice whether due to cholandocarcinoma. carcinoma head of pancreas or metastatic spread to liver
from remote cancer is a common problem. Only a small iiumber of patients with malignant biliarv
obstruction are suitable for radical surgery2. For the remainder effective palliation is necessary because
obstructive biliary system can lower the quality of life, causes pruritis and predisposes the patient to
cholangitis. nutritional disturbances and progressive liver failure. ERCP is preferred method for biliarv
stenting in these patients and when this fails either percutaneous transhepatic biliary stenting or
eudoscopic plus percutaneous transhepatic (combined technique) may be tried3,4.
Around 10-15% of patients were not suitable for endoscopic treatment. These patients were then
managed by a percutaneous approach. The combined procedure was developed for these cases5. In this
technique, the stricture is crossed percutaneously through a 6 French track. A guide reserved for
selected patients in whom endoscopic route wire is then passed through into the duodenum and picked
up using an endoscope. It is then possible to proceed endoscopicallv. The success rate of the technique
is close to 100%4 and the complication rate is low6,7.
The most important recent development is the manufacture of expandable metallic stents. These
devices can be introduced via a 7 French track and expand up to 1cm diameter. They may also be
placed endoscopically. The time to occlusion of these stents is a little longer than plastic stents8. The
cost remains the major disadvantage, with average price around 1000 US dollars for the metal stent.
This study reports our experience of percutaneous transhepatic biliary stenting in malignant biliary
strictures.
Material and Method 
This retrospective study conducted during the period of 1996-1999 includes 17 patients with 6 males
and 11 females. Age range was 20-90 years with mean age of 61 years. Obstructive jaundice was
present in all patients. Total bilirubin ranged from 5.0-23.0mg% with mean of 15.5mg%. Pruritis was
present in 9 patients and 2 patients had associated cholangitis. All patients had inoperable malignant
biliary obstruction. The causes are given in table 1.
The stricture was proximal or hilar in 8 (47%). mid CBD in 2 (12%) and distal CBD in 7 (41%)
patients. The diagnosis of malignancy was made on radiological and histological grounds. Endoscopic
stentings were attempted in all these patients and failed. Procedure was done by percutaneous
transhepatic approach alone in 14 patients and with combined approach in 3 patients. We used plastic
stems of different caliber i.e. 7F. 8.5F, 10F and 12F and metallic wallstent in one patient. Double
mushroom stents were also placed in 4 patients. Double stents were placed in 3 patients.
Technique
Baseline liver function tests were done prior to procedure. Patients were kept on fasting for 6 hours
before the procedure. All patients received prophylactic intravenous antibiotics. Sedation and parenteral
analgesia were required in most patients due to pain. A routine anticoagulant profile including
prothronibin time, activated partial tliromboplastin time and platelets counts were routinely done before
the procedure. The results should be within normal range and corrected with fresh frozen plasma and
platelets aggi egate.
All percutaneous transhepatic biliarv stenting. procedures were performed under sonographic and
fluoroscopic guidance. After taking all aseptic measures percutaneous cholangiogram was performed
and a suitable duct, either right or left was selected for puncture. If the stricture was at the hilum. the
duct draining the largest hepatic segment either right or left lobe was chosen. The selected duct was
punctured with 1 8G needle and a guide wire was passed. In five patients two staged procedure was
done. An external drainage was performed first followed by stenting after 3-5 days. In others. stricwre
negotiated with the w ire and advanced into fourth part of duodenum at the initial stage. Some very
tight strictures required balloon dilatation before stenting. Stents were passed through a sheath. For
combined procedure. the guide wire was retrieved with the help of endoscope and the stem was placed
by peroral route over the wire (Figure 1).
Finalk. an external drain was left in. Cholangiogram through the external drain was repeated after 2
days to check the patency of stent (Figure 2).
If any blockage was found. attempts were made to reopen the stent by flushing or passing a wire.
Failing this a second stent was placed alongside the first one (Figure 3).
The external drain tube was removed at the end. Patient stayed in the hospital for atleast 3 days after
the procedure and was later followed in out patient clinics. Hospital stay was prolonged in patients who
developed complications. Serial liver function tests were done at 2-3 weeks intervals.
Results 
Results were analyzed on the basis of improvement patients’ general condition more than 50 %
reduction of serum bilirubin level, patient’s survival time and complication rate.
Overall results arc summarized in table 2.
A total of 1 7 patients were included in this study.
In almost all the cases, the patient’s general condition improved and pruritis and jaundice reduced.
Serum bilirubin levels were also reduced to more than 50% within 2 weeks in all the live patients.
Procedure was successful in 16 out of 17 patients (94%). In one patient the procedure failed due to
difficulty in passing guide wire through the stricture and therefore only external drainage was placed.
Patient’s survival time ranged from 4 days to more than one vear with mean survival time of 67 days.
Two patients remained alive longer than one vear the survival was also influenced by the patients age
and co-morbids e.g. diabetes mellitus, hypertension, renal failure and ischemic heart disease. The
survival time was short particularly in these patients. On the other hand, the patients who were young
with no other co-morbidity, the complications of procedure were less and survival time longer.
The commonest complication was cholangitis observed in 6(35%) patients. Out of these three had
fever, chills not lasting more than 48hrs and controlled with antibiotics, 2 patients had severe
septicemia and one had liver abscess formation following cholangitis. Three (17%) patients had biliary
leakage. Out of these one had biliary peritonitis and the other 2 remained asymptomatic with leakage
detected incidentally on follow-up ultrasounds. Biloma formation was noted in 2 (11%) patients. Most
patients had more than one complication (Table 3).
One patient expired due to procedure related complications i.e. septicemia. Overall, major
complications which include death, severe septicemia. biliary peritonitis occurred in 4/1 7 (23%)
patients while minor complications including cholangitis. fever. bacteraemia, pain, minor bleeding or
leakage were seen in 3/17 (18%) patients. None of the patients had significant hemorrhage. Four
patients had stent occlusion with duration ranging from one week to 3 months.
Discussion 
Patients with inoperable tumors causing obstructive jaundice have limited life expectancy but may
suffer from distressing symptoms, such as intractable pruritus. interventional techniques for relieving
jaundice in pancreatic head carcinoma have been shown to be as effective as surgical bypass9,10. More
proximal tumor may be very difficult to palliate surgically without resorting to complex procedures.
Endoprosthesis are particularly useful in these patients11.
The aim of treatment for biliary stenting is to keep the biliary ducts patent. The ideal procedure should
have a low rate of complications and provide the patients with good quality of life. Transhepatic biliary
stenting should be limited to patients in whom curative surgical and palliative endoscopic treatments
are not possible since endoscopic stenting is less invasive and therefore has a lower complication
rate12. However, transhepatic stenting is associated with fewer complications than palliative surgery13.
Furthermore, presence of duodenal diverticula or tight proximal stricture makes endoscopic procedures
difficult or impossible. Transhepatic route is preferred in these situations.
Late complications like stent occlusion and displacement have also been reported11-13. Stent occlusion
leads to cholangitis14-16. Self-expandable metallic endoprosthesis have been developed during the last
few years in the hope of reducing the stent occlusion. In bile ducts, experimental studies with Gianturco
and Palmatz stents showed good results without complications. Coon reported good results with
Gianturco stents in bile ducts in a series of 30 patients17.
In this study, we reviewed the outcome of percutaneous transhepatic insertion of biliary stents. We
included only those patients in which surgery was not possible and endoscopic stenting had failed.
These patients were referred from gastroenterologists and surgeons. Most of the patients had advanced
disease at the time of stentings. Two had existing cholangitis.
The overall success rate of the procedure was quite satisfactory (94%). In one patient. the stricture was
not negotiable by the guide wire and we placed external biliary drainage catheter. The results are
comparable with the study by Doctor et al, which showed a technical success of 89% in 49 patients
with plastic stents18.
We used plastic stents of different calibers ranging from 7F-12F. Double stents were also placed in
three patients. In one patient self-expandable metallic stent was also placed. The chances of stent
occlusion are closely related to stent diameter and number of stents. The wider the stent diameter, the
lesser the chance of occlusion19. Two stents are less likely to be occluded than one. 12F double
mushroom plastic stents remained patent upto 3 months longer than the stents with smaller diameter,
which were occluded as early as one week. Expandable metallic stents remained patent for six months.
Metallic expandable stents are much better than plastic stents but cost is the major limitatioii20-21.
All patients included in our study had malignant biliary obstruction, carcinoma head of pancreas and
cholangiocarcinoma being the most common causes. Overall complications occurred in 7 (41%)
patients. The commonest complication was acute cholangitis, which occurred in 6 (35%) patients and
was mostly related to stent occlusion. The incidence is relatively high as compared to literature review
which showed 14%22. The other common complications were bile leakage and biloma formation in
17% and 11% of patients respectively. One patient developed biliary peritonitis. One patient died from
liver abscess. All these complications were diagnosed on ultrasound and CT scan.
The high complication rate may be due to multiple factors e.g, advanced disease, preexisting
comorbids. single stage procedure and the use of plastic rather than metal stents. We placed stents at the
initial time in most cases without doing preliminary drainage procedure for 4-5 days. This drainage
procedure relieves the obstruction and reduces the chances of cholangitis and sepsis, which in turn
decreases the mortality and morbidity. We performed biliar drainage procedure in 5 (29%) patients
before the stent insertion. The main reason of doing single stage procedure and using plastic stents was
to cut down the cost burden to the patient as in many cases patients were non-affording.
Mean survival time was 67 days with range of 4 days to 8 months in 15 patients. Two patients were
alive after 1 year. Most of the patients with short survival time also had other niorbidities like diabetes
mellitus. renal failure. ischemic heart disease and hypertension. The survival time was higher in young
patients with no other co morbidity.
Our results suggest that percutaneous plastic stents can be used safely and effectively in patients who
had failed endoscopic stenting and had inoperable malignant biliary stricture. Although the
complication rate is high and survival time is low, this procedure can benefit the patients by reducing
their problems related to obstructive jaundice, pruritus and nutritional disturbances. The procedure is
particularly beneficial in younger patients, those with no other co-morbid and patients requiring
chemotherapy.
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